Apexigen Stock Fundamentals
| APGNDelisted Stock | USD 0.39 0.00 0.00% |
Apexigen fundamentals help investors to digest information that contributes to Apexigen's financial success or failures. It also enables traders to predict the movement of Apexigen Stock. The fundamental analysis module provides a way to measure Apexigen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Apexigen stock.
Apexigen |
Apexigen Company Shares Owned By Insiders Analysis
Apexigen's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Apexigen Shares Owned By Insiders | 8.81 % |
Most of Apexigen's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Apexigen is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
CompetitionBased on the latest financial disclosure, 8.81% of Apexigen are shares owned by insiders. This is 41.96% lower than that of the Biotechnology sector and 37.87% lower than that of the Health Care industry. The shares owned by insiders for all United States stocks is 12.69% higher than that of the company.
Apexigen Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Apexigen's current stock value. Our valuation model uses many indicators to compare Apexigen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Apexigen competition to find correlations between indicators driving Apexigen's intrinsic value. More Info.Apexigen is rated below average in return on equity category among related companies. It is rated below average in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Apexigen by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Apexigen's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Apexigen's earnings, one of the primary drivers of an investment's value.Apexigen Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Apexigen's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Apexigen could also be used in its relative valuation, which is a method of valuing Apexigen by comparing valuation metrics of similar companies.Apexigen is currently under evaluation in shares owned by insiders category among related companies.
Apexigen Fundamentals
| Return On Equity | -15.98 | |||
| Return On Asset | -0.89 | |||
| Current Valuation | 205.33 K | |||
| Shares Outstanding | 24.86 M | |||
| Shares Owned By Insiders | 8.81 % | |||
| Shares Owned By Institutions | 13.54 % | |||
| Number Of Shares Shorted | 64.45 K | |||
| Price To Book | 2.32 X | |||
| EBITDA | (32.58 M) | |||
| Net Income | (32.07 M) | |||
| Cash And Equivalents | 21.62 M | |||
| Cash Per Share | 1.01 X | |||
| Total Debt | 106 K | |||
| Debt To Equity | 0.05 % | |||
| Current Ratio | 1.24 X | |||
| Book Value Per Share | (0.09) X | |||
| Cash Flow From Operations | (30.69 M) | |||
| Short Ratio | 1.72 X | |||
| Earnings Per Share | (1.71) X | |||
| Target Price | 0.64 | |||
| Number Of Employees | 11 | |||
| Beta | 3.62 | |||
| Market Capitalization | 9.57 M | |||
| Total Asset | 22.86 M | |||
| Retained Earnings | (176.79 M) | |||
| Working Capital | 4.73 M | |||
| Z Score | 38.91 | |||
| Net Asset | 22.86 M |
About Apexigen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Apexigen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Apexigen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Apexigen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Apexigen Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. The company was founded in 2010 and is based in San Carlos, California. Apexigen operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 22 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Apexigen information on this page should be used as a complementary analysis to other Apexigen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Apexigen Stock
If you are still planning to invest in Apexigen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Apexigen's history and understand the potential risks before investing.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |